[Risk Factors of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myeloid Malignancies].
Making sure pre-transplant CRP≤10 mg/L and CD34<sup>+</sup> cell dose ≥5×10<sup>6</sup>/kg in the graft may have an effect on preventing the occurrence of primary PGF after allo-HSCT. The occurrence of primary PGF may affect the OS rate of transplant patients, and early prevention and treatment are required.
Authors
- Xiaohua Luo (ORCID: https://orcid.org/0000-0002-0657-7738)
- Xiaoqiong Tang (ORCID: https://orcid.org/0000-0002-6018-736X)
- Mingyan Liao (ORCID: https://orcid.org/0000-0002-6841-2664)
- Lin-Yi Zhang
- Qing Xiao (ORCID: https://orcid.org/0000-0001-8969-6275)
- Lin Liu (ORCID: https://orcid.org/0000-0001-8973-8738)
- Yiying Xiong
- Hongbin Zhang (ORCID: https://orcid.org/0000-0003-4207-0560)
- Li Wang (ORCID: https://orcid.org/0000-0002-4658-2558)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.06.037
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article